Literature DB >> 24551638

A Cross-sectional Study of Clinical, Histopathological and Direct Immunofluorescence Spectrum of Vesiculobullous Disorders.

Arundhathi S1, Ragunatha S2, Mahadeva K C3.   

Abstract

BACKGROUND: Accurate diagnosis of vesiculobullous lesions of skin requires evaluation of clinical, histopathologic and immunofluorescence findings.
METHODS: A cross-sectional study of 68 patients to evaluate the clinical, histopathological and direct immunofluorescence (DIF) features in the diagnosis of cutaneous vesiculobullous disorders. The patients with vesiculobullous lesions were subjected to clinical examination regarding socio-demographic and clinical data. Two biopsy specimens were taken, one from intact vesicle for histopathological study and another from perilesional normal looking skin or oral mucosa for DIF.
RESULTS: Vesiculobullous lesions constituted 22.08% of total number of skin biopsies. The most common clinical diagnosis was pemphigus vulgaris (PV) in 36 cases, followed by bullous pemphigoid (BP) in 8 cases, pemphigus foliaceous (PF) in 6 cases, and dermatitis herpetiformis (DH) in 4 cases. Characteristic histopathological features were present in 26 cases of PV, 9 cases of BP and 4 cases of PF, and 17.7% showed non- specific changes. DIF was positive in 24 cases of PV, 9 cases of BP and 3 cases of PF, and negative in 34.92% of cases.
CONCLUSION: Clinical, histopathological and DIF features together or in combination help in the final diagnosis of vesiculobullous disorders. Individually, none of these methods are diagnostic in each and every case.

Entities:  

Keywords:  Bullous Pemphigoid; Direct immunofluorescence; Pemphigus; Vesiculobullous disorders

Year:  2013        PMID: 24551638      PMCID: PMC3919394          DOI: 10.7860/JCDR/2013/7019.3760

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Immunofluorescence of the immunobullous disorders part one : Methodology.

Authors:  S C Huilgol; B S Bhogal; M M Black
Journal:  Indian J Dermatol Venereol Leprol       Date:  1995 Jul-Aug       Impact factor: 2.545

2.  A clinico-pathological study of 70 cases of pemphigus.

Authors:  S R Arya; A G Valand; K Krishna
Journal:  Indian J Dermatol Venereol Leprol       Date:  1999 Jul-Aug       Impact factor: 2.545

3.  Pemphigus: analysis of 1209 cases.

Authors:  Cheyda Chams-Davatchi; Mahin Valikhani; Maryam Daneshpazhooh; Nafiseh Esmaili; Kamran Balighi; Zahra Hallaji; Massoume Barzegari; Maryam Akhiani; Zahra Ghodsi; Hosein Mortazavi; Zahra Naraghi
Journal:  Int J Dermatol       Date:  2005-06       Impact factor: 2.736

4.  Direct immunofluorescence in cutaneous vesiculobullous lesions.

Authors:  Y K Inchara; T Rajalakshmi
Journal:  Indian J Pathol Microbiol       Date:  2007-10       Impact factor: 0.740

Review 5.  Pemphigus in India.

Authors:  Amrinder J Kanwar; Dipankar De
Journal:  Indian J Dermatol Venereol Leprol       Date:  2011 Jul-Aug       Impact factor: 2.545

6.  Bullous pemphigoid in Liguria: a 2-year survey.

Authors:  E Cozzani; A Parodi; A Rebora; S Delmonte; M Barile; A Nigro; L Priano; G Troiano; P L Patri
Journal:  J Eur Acad Dermatol Venereol       Date:  2001-07       Impact factor: 6.166

7.  [Immunopathologic changes in 115 patients with bullous pemphigoid].

Authors:  W Kippes; E Schmidt; A Roth; B Rzany; E B Bröcker; D Zillikens
Journal:  Hautarzt       Date:  1999-12       Impact factor: 0.751

8.  Eosinophilic spongiosis in bullous pemphigoid.

Authors:  K Nishioka; K Hashimoto; I Katayama; C Sarashi; T Kubo; S Sano
Journal:  Arch Dermatol       Date:  1984-09
  8 in total
  2 in total

1.  Histologic characterization of cellular infiltration in autoimmune subepidermal bullous diseases in a tertiary hospital in Saudi Arabia.

Authors:  Hessah F BinJadeed; Alanoud M Alyousef; Fahad M Alsaif; Ahmed A Alhumidi; Homaid O Alotaibi
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-04-24

2.  A Clinicopathological and Immunofluorescence Study of Intraepidermal Immunobullous Diseases.

Authors:  Keya Basu; Moumita Chatterjee; Abhishek De; Moumita Sengupta; Chhanda Datta; Pradip Mitra
Journal:  Indian J Dermatol       Date:  2019 Mar-Apr       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.